Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.15 USD | +0.49% | -4.12% | +60.43% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 57.03M | Capitalization | 243M |
---|---|---|---|---|---|
Net income 2024 * | -46M | Net income 2025 * | -15M | EV / Sales 2024 * | - |
Net cash position 2024 * | 108M | Net cash position 2025 * | 134M | EV / Sales 2025 * | 1.91 x |
P/E ratio 2024 * |
-5.31
x | P/E ratio 2025 * |
-17.9
x | Employees | 49 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.87% |
Latest transcript on Actinium Pharmaceuticals, Inc.
1 day | +0.49% | ||
1 week | -4.12% | ||
1 month | +5.84% | ||
3 months | -4.45% | ||
6 months | +77.95% | ||
Current year | +60.43% |
Managers | Title | Age | Since |
---|---|---|---|
Sandesh Seth
CEO | Chief Executive Officer | 60 | 12-02-29 |
Steve O'Loughlin
DFI | Director of Finance/CFO | 39 | 15-10-12 |
Monideepa Roy
CTO | Chief Tech/Sci/R&D Officer | - | 21-09-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 13-11-07 | |
C. Nicholson
BRD | Director/Board Member | 68 | 07-12-31 |
Ajit Shetty
BRD | Director/Board Member | 77 | 17-03-27 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.15 | +0.49% | 198,907 |
24-05-30 | 8.11 | +1.37% | 203,068 |
24-05-29 | 8 | -2.68% | 164,855 |
24-05-28 | 8.22 | -3.29% | 172,394 |
24-05-24 | 8.5 | +0.95% | 243,739 |
Delayed Quote Nyse, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.43% | 243M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- ATNM Stock